Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.
about
Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Development of gene therapy: p ...... denosine deaminase deficiency.
@en
Development of gene therapy: p ...... denosine deaminase deficiency.
@nl
type
label
Development of gene therapy: p ...... denosine deaminase deficiency.
@en
Development of gene therapy: p ...... denosine deaminase deficiency.
@nl
prefLabel
Development of gene therapy: p ...... denosine deaminase deficiency.
@en
Development of gene therapy: p ...... denosine deaminase deficiency.
@nl
P2860
P356
P1476
Development of gene therapy: p ...... denosine deaminase deficiency.
@en
P2093
Claudia A Montiel-Equihua
H Bobby Gaspar
P2860
P356
10.2147/SCCAA.S5570
P577
2009-12-22T00:00:00Z